PL402710A1 - Kompozycje farmaceutyczne zawierajace imatinib lub jego farmaceutycznie dopuszczalna sól oraz sposoby ich otrzymywania - Google Patents
Kompozycje farmaceutyczne zawierajace imatinib lub jego farmaceutycznie dopuszczalna sól oraz sposoby ich otrzymywaniaInfo
- Publication number
- PL402710A1 PL402710A1 PL402710A PL40271011A PL402710A1 PL 402710 A1 PL402710 A1 PL 402710A1 PL 402710 A PL402710 A PL 402710A PL 40271011 A PL40271011 A PL 40271011A PL 402710 A1 PL402710 A1 PL 402710A1
- Authority
- PL
- Poland
- Prior art keywords
- methods
- pharmaceutically acceptable
- acceptable salt
- pharmaceutical compositions
- imatinib
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Przedmiotem wynalazku są kompozycje farmaceutyczne zawierające imatinib lub jego farmaceutycznie dopuszczalną sól oraz sposoby ich otrzymywania.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1732CH2010 | 2010-06-21 | ||
EP10460039 | 2010-09-20 | ||
PCT/EP2011/003020 WO2011160798A1 (en) | 2010-06-21 | 2011-06-17 | Pharmaceutical compositions comprising imatinib or pharmaceutically acceptable salt thereof and processes for the manufacture thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
PL402710A1 true PL402710A1 (pl) | 2013-09-30 |
PL234542B1 PL234542B1 (pl) | 2020-03-31 |
Family
ID=44358103
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL402710A PL234542B1 (pl) | 2010-06-21 | 2011-06-17 | Sposób otrzymywania kompozycji farmaceutycznej zawierającej imatinib lub jego farmaceutycznie dopuszczalną sól |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP2582362A1 (pl) |
EA (1) | EA029416B1 (pl) |
PL (1) | PL234542B1 (pl) |
WO (1) | WO2011160798A1 (pl) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9750700B2 (en) | 2011-06-22 | 2017-09-05 | Natco Pharma Limited | Imatinib mesylate oral pharmaceutical composition and process for preparation thereof |
JP5928159B2 (ja) * | 2012-05-28 | 2016-06-01 | ニプロ株式会社 | 医薬組成物 |
EP2749271A1 (en) * | 2012-12-31 | 2014-07-02 | Deva Holding Anonim Sirketi | Optimized manufacturing method and pharmaceutical formulation of imatinib |
GB201304699D0 (en) * | 2013-03-15 | 2013-05-01 | Remedica Ltd | Pharmaceutical compositions |
EP2803353B1 (en) | 2013-05-14 | 2018-05-23 | Hetero Research Foundation | Compositions of Imatinib |
CN104414988B (zh) * | 2013-08-28 | 2018-07-06 | 山东新时代药业有限公司 | 一种达沙替尼片剂及其制备工艺 |
EP3407874B1 (en) * | 2016-01-25 | 2024-05-22 | KRKA, d.d., Novo mesto | Fast dispersible pharmaceutical composition comprising tyrosine-kinase inhibitor |
EP3257499A1 (en) | 2016-06-17 | 2017-12-20 | Vipharm S.A. | Process for preparation of imatinib methanesulfonate capsules |
CN107648237B (zh) * | 2016-07-26 | 2022-03-04 | 江苏豪森药业集团有限公司 | 氨基嘧啶类化合物的药物组合物及其制备方法 |
US11285152B2 (en) | 2017-07-20 | 2022-03-29 | Kashiv Biosciences, Llc | Stable oral pharmaceutical composition of imatinib |
BR112022000507A2 (pt) | 2019-07-15 | 2022-05-10 | Novartis Ag | Formulações de (s)-3-amino-6-metóxi-n-(3,3,3-trifluoro-2-hidróxi-2-metilpropil)-5-(trifluorometil)picolinamida |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW225528B (pl) | 1992-04-03 | 1994-06-21 | Ciba Geigy Ag | |
GB0209265D0 (en) | 2002-04-23 | 2002-06-05 | Novartis Ag | Organic compounds |
ATE445392T1 (de) | 2005-08-15 | 2009-10-15 | Siegfried Generics Int Ag | Filmtablette oder granulat enthaltend ein pyridylpyrimidin |
JP2010540465A (ja) * | 2007-09-25 | 2010-12-24 | テバ ファーマシューティカル インダストリーズ リミティド | 安定なイマチニブ組成物 |
-
2011
- 2011-06-17 EP EP11733997.8A patent/EP2582362A1/en not_active Withdrawn
- 2011-06-17 WO PCT/EP2011/003020 patent/WO2011160798A1/en active Application Filing
- 2011-06-17 PL PL402710A patent/PL234542B1/pl unknown
- 2011-06-17 EA EA201300034A patent/EA029416B1/ru not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2011160798A1 (en) | 2011-12-29 |
EA201300034A1 (ru) | 2013-05-30 |
EA029416B1 (ru) | 2018-03-30 |
PL234542B1 (pl) | 2020-03-31 |
EP2582362A1 (en) | 2013-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL402710A1 (pl) | Kompozycje farmaceutyczne zawierajace imatinib lub jego farmaceutycznie dopuszczalna sól oraz sposoby ich otrzymywania | |
PH12015500064B1 (en) | Imidazotriazinecarbonitriles useful as kinase inhibitors | |
DK3284467T3 (da) | Nikotinholdige farmaceutiske sammensætninger | |
IN2014MN02598A (pl) | ||
IN2014DN10670A (pl) | ||
CR20140106A (es) | Compuestos y composiciones como inhibidores de la quinasa c-kit | |
EP2609064A4 (en) | PHARMACEUTICAL COMPOSITIONS WITH POH DERIVATIVES | |
DK2673262T3 (da) | Fremgangsmåder til fremstilling af quinolinforbindelser og farmaceutiske sammensætninger indeholdende sådanne forbindelser | |
ZA201206254B (en) | Novel salts for the manufacture of pharmaceutical compositions | |
MX2013001677A (es) | Formulaciones estables de linaclotida. | |
IL229113A0 (en) | An[(1h-pyrazol-1-yl)aryl]1h-indole or 1h-indazole-3-carboxamide derivatives, their preparation and use as p2y12 antagonists | |
TN2012000392A1 (en) | Oral formulations and lipophilic salts of methylnaltrexone | |
MX2014004196A (es) | Citramida de rasagilina. | |
IL231383A0 (en) | History of imidazole amines, their preparation and pharmaceutical preparations containing them | |
MX2014013664A (es) | N-etil-4-hidroxil-1-metil-5-(metil(2,3,4,5,6-pentahidroxietil)ami no)-2-oxo-n-fenil-1,2-dihidroquinolin-3-carboxamida. | |
WO2014033526A9 (en) | Pharmaceutical compositions of etoricoxib | |
EP2536285A4 (en) | SUBSTITUTED CONDENSED IMIDAZOLE DERIVATIVES, PHARMACEUTICAL COMPOUNDS AND USER METHOD THEREFOR | |
IT1403282B1 (it) | Procedimento per la preparazione di linagliptin | |
IT1402029B1 (it) | Procedimento per la preparazione di erlotinib | |
ITBS20100012A1 (it) | Procedimento per la preparazione di fluazinam | |
EP2871187A4 (en) | NOVEL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS ACTIVE INGREDIENT | |
DK2588097T3 (da) | Farmaceutiske sammensætninger omfattende paracetamol og fremgangsmåde til fremstilling af samme | |
MX367773B (es) | Forma salina sólida de la alfa-6-mpeg6-o-hidroxicodona como agonistas opioides y sus usos. | |
HUE054955T2 (hu) | 3-Formilrifamicin S 3-(4-cinnamil-L-piperazinil)-amino származékait tartalmazó gyógyszerészeti készítmények | |
TR201010859A2 (tr) | Sefdinir içeren tablet formları. |